This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

AAE581

Novartis AG

Drug Names(s): AAE581

Description: AAE581 is an orally available inhibitor of cathepsin K. Cathepsin K is a enzyme that degrades bone matrix (collagen). AAE581 inhibits cathepsin K in osteoclasts, leading to reduced collagen breakdown and decreased bone resorption.


AAE581 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug